ATC Group: C09CA01 Losartan

Position of C09CA01 in the ATC hierarchy

Level	Code	Title
1	C	Cardiovascular system
2	C09	Agents acting on the renin-angiotensin system
3	C09C	Angiotensin II antagonists, plain
4	C09CA	Angiotensin II antagonists, plain
5	C09CA01	Losartan

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	50 mg

Active ingredients in C09CA01

Active Ingredient
Losartan
Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.

Related product monographs

Document	Type	Information Source
ARBLI Oral suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)
COZAAR Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
COZAAR Film-coated tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
COZAAR Powder and solvent for oral suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
LOSAR Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
ZAARIO Film-coated tablet	MPI, Generic	Health Products Regulatory Authority (ZA)

Medicines in this ATC group

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.